Totaligent, Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026 with the U.S. Securities and Exchange Commission on November 16, 2026, reporting continued operating losses and a stockholders' deficit.

Key Highlights

  • Net loss for Q3 2026: The company reported a net loss of $65,228 for the three months ended September 30, 2026, compared to a net loss of $117,417 for the same period in 2025.
  • Nine-month net loss: For the nine months ended September 30, 2026, the company reported a net loss of $187,092, compared to $337,667 for the same period in 2025.
  • Total revenue: Total revenue for the three months ended September 30, 2026 was $578, all of which was attributed to related parties, compared to $2,248 for the three months ended September 30, 2025.
  • Stockholders' deficit: The company reported a total stockholders' deficit of $2,056,831 as of September 30, 2026, compared to a deficit of $2,164,267 as of December 31, 2025.
  • Shares outstanding: Common shares outstanding increased to 380,841,775 as of September 30, 2026, up from 213,601,313 as of December 31, 2025.
  • Cash position: Cash on hand was $1,913 as of September 30, 2026, down from $4,689 as of December 31, 2025.
  • Convertible notes in default: Convertible notes payable in default totaled $811,335 as of September 30, 2026, compared to $911,335 as of December 31, 2025.

Totaligent's Financial Position and Operating Results for the Quarter Ended September 30, 2026

According to the filing, Totaligent, Inc. recorded total revenue of $578 for the three months ended September 30, 2026, consisting entirely of revenue from related parties, against cost of revenue of $210, yielding a gross profit of $368. For the nine-month period, total revenue was also $578, unchanged from the three-month figure, as the company reported no revenue in the first two quarters of 2026.

The filing disclosed total operating expenses of $33,788 for the three months ended September 30, 2026, which included professional fees of $12,514 and general and administrative expenses of $21,274. For the nine-month period, total operating expenses were $179,172, including consulting expenses of $59,469, professional fees of $63,159, and general and administrative expenses of $56,544. The company reported a net operating loss of $33,420 for the three months and $178,804 for the nine months ended September 30, 2026.

As of September 30, 2026, the company's balance sheet reflected total assets of $219,536, which included capitalized software of $182,193 and property and equipment, net, of $28,031. Total liabilities stood at $2,276,367, including accrued compensation to related parties of $805,298, a derivative liability of $129,784, and notes payable of $133,608. The accumulated deficit as of September 30, 2026 was $2,747,723, according to the filing. The company also noted a gain on change in fair value of derivative liability of $43,710 for the nine-month period ended September 30, 2026, compared to a loss of $63,534 for the same period in 2025. The filing contains forward-looking statements that the company described as subject to risks and uncertainties that could cause actual results to differ materially from those projected.

What Was Disclosed

Totaligent, Inc. filed a quarterly report covering the period ended September 30, 2026, disclosing a net loss of $65,228 for the quarter, a stockholders' deficit of $2,056,831, cash of $1,913, and 380,841,775 common shares outstanding as of November 16, 2026.